ERNA Earnings

Quarterly EPS
$-1842.50
Q3 2024
$-44.63
Q4 2024
$-57.76
Q1 2025
$-15.19
Q2 2025
$-3.75
Q3 2025
$-2.27
Q4 2025
$-6.95
Q1 2026
$-3.40
Q2 2026
Latest RevenueN/A
Latest Net Income-4009000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$3.400-4009000+77.6%
Q1 2026-$6.950-5506000+88.0%
Q4 2025-$2.270-1502000-100.0%+94.9%
Q3 2025-$3.750-1240000-100.0%+99.8%
Q2 2025-$15.190-3139000-100.0%+96.0%
Q1 2025-$57.760-8202000-100.0%+87.5%
Q4 2024-$44.631.0K-5759000-94.1%+89.5%
Q3 2024-$1,842.50487.0K-26604000+854.9%-377.0%
Q2 2024-$383.5047.0K-5529000
Q1 2024-$461.2547.0K-6647000
Q4 2023-$426.5817.0K-6212000
Q3 2023-$386.2551.0K-5591000
Ernexa Therapeutics (ERNA) — Earnings